VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PBH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PBHPrestige Consumer Healthcare Inc.
$42.98$2.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPBHBalance Sheet

Prestige Consumer Healthcare Inc. (PBH) Balance Sheet

26Y historyFree accessUpdated daily

The $1.0B acquisition in 2027Q1 doubled total debt to $2.1B, lifting D/E to 1.08 from 0.55 in 2026Q4, though liquidity remains solid with a current ratio of 3.23.

Income StatementBalance SheetCash FlowRatios

PBH Balance Sheet

Annual statement

PBH Balance Sheet

Prestige Consumer Healthcare Inc. (PBH) balance sheet — 26-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'04Mar'03Mar'02Mar'01
Total Current Assets492.13M431.48M448.33M375.04M391.74M293.27M269.83M365.65M300.94M303.48M334.43M249.01M201.71M177.19M164.17M147.03M107.58M112.15M103.56M85.38M83.77M86.01M79.66M30.75M3.53M7.88M0
Cash & Short-Term Investments46.52M63.87M97.88M46.47M58.49M27.18M32.3M94.76M27.53M32.55M41.85M27.23M21.32M28.33M15.67M19.02M13.33M41.1M35.18M6.08M13.76M8.2M5.33M3.39M3.53M7.88M0
Cash Only46.52M63.87M97.88M46.47M58.49M27.18M32.3M94.76M27.53M32.55M41.85M27.23M21.32M28.33M15.67M19.02M13.33M41.1M35.18M6.08M13.76M8.2M5.33M3.39M3.53M7.88M0
Short-Term Investments000000000000000000000000000
Accounts Receivable244.12M191.92M194.29M176.78M167.02M139.33M114.67M150.52M148.79M140.88M136.74M95.25M87.86M65.05M73.05M60.23M44.39M30.62M36.02M44.22M35.17M40.04M35.92M15.73M000
Days Sales Outstanding63.6364.3462.3357.3454.0646.7944.3757.0555.6649.3956.5843.1244.8739.4542.7649.8448.1537.0142.0549.4240.2849.2643.2265.31---
Inventory179.2M159.13M147.71M138.72M162.12M120.34M114.96M116.03M119.88M118.55M115.61M91.26M74M65.59M60.2M51.11M39.75M29.16M26.98M29.7M30.17M33.84M21.58M9.75M000
Days Inventory Outstanding112.76112.99107.12101.08117.7894.23105.99103.09104.1393.12110.5398.2587.5891.4379.587.387.673.6265.8968.5671.9188.5955.7398.08---
Other Current Assets016.56M8.44M13.08M4.12M0004.74M040.23M10.11M8.1M6.54M6.35M5.28M10.1M11.27M5.38M3.07M2.73M3.93M8.85M1.65M000
Total Non-Current Assets4.23B3.12B2.95B2.94B2.96B3.38B3.16B3.15B3.14B3.46B3.58B2.7B2.47B1.62B1.58B1.61B949.34M679.26M697.82M963.78M979.65M952.63M921.48M295.87M000
Property, Plant & Equipment161.63M171.25M127.84M89.33M89.53M98.53M102.77M90.72M51.18M52.55M50.59M15.54M13.74M9.6M9.9M1.3M1.44M1.4M1.37M1.43M1.45M1.65M2.32M880K000
Fixed Asset Turnover6.95x6.36x8.90x12.60x12.60x11.03x9.18x10.62x19.07x19.81x17.43x51.88x52.00x62.72x63.02x338.26x233.04x216.35x228.76x227.92x219.90x179.47x130.52x99.91x---
Goodwill705.26M581.11M527.42M527.73M527.55M578.98M578.08M575.18M578.58M620.1M615.25M360.19M290.65M190.91M167.55M173.7M154.9M111.49M114.24M308.92M310.95M297.94M055.59M000
Intangible Assets3.36B2.3B2.3B2.32B2.34B2.7B2.48B2.48B2.51B2.78B2.9B2.32B2.13B1.39B1.37B1.4B786.36M559.23M577.59M646.68M657.16M637.2M294.54M0000
Long-Term Investments00000000-399.57M-26K-715.09M-10.11M-8.1M-6.54M-6.35M-5.28M-5.29M-6.35M-4.02M-3.07M-2.73M-3.23M-5.7M0000
Other Non-Current Assets5.58M2.17M3.27M5.72M3M3.27M2.86M2.96M3.13M3.57M7.45M1.32M28.6M23.15M24.94M35.71M6.63M7.15M4.62M6.75M10.1M15.85M624.61M239.39M000
Total Assets4.72B3.55B3.4B3.32B3.35B3.67B3.43B3.51B3.44B3.76B3.91B2.95B2.67B1.8B1.74B1.76B1.06B791.41M801.38M1.05B1.06B1.04B1B326.62M142.06M174.04M151.29M
Asset Turnover0.29x0.31x0.33x0.34x0.34x0.30x0.28x0.27x0.28x0.28x0.23x0.27x0.27x0.34x0.36x0.25x0.32x0.38x0.39x0.31x0.30x0.29x0.30x0.27x0.50x0.27x0.06x
Asset Growth %79.53%4.27%2.53%-1.05%-8.63%7.04%-2.41%2.12%-8.5%-3.85%32.64%10.47%48.66%3.21%-1.05%66.36%33.55%-1.24%-23.62%-1.34%2.38%3.75%206.51%129.92%-18.38%15.04%-
Total Current Liabilities168.5M120.92M106.62M117.05M160.72M143.42M122.14M149.88M126.98M123.2M162.01M106.68M99.04M84.36M96.67M63.92M54.21M55.65M34.23M37.89M40.91M35.73M38.91M14.54M000
Accounts Payable44.02M22.79M18.93M38.98M62.74M55.76M45.98M62.38M56.56M61.39M70.22M38.3M46.12M48.29M51.38M26.73M21.61M12.77M18.05M20.54M19.3M18.07M21.7M5.28M000
Days Payables Outstanding23.8816.1813.7228.445.5843.6642.3955.4249.1348.2267.1341.2354.5867.3167.8545.6547.6332.2444.0847.4246.0147.2956.0553.13---
Short-Term Debt02.99M00000000000000029.59M3.55M3.55M3.55M3.73M3.73M2M000
Deferred Revenue (Current)0000000000492K000000000012.14M-3.73M-2M000
Other Current Liabilities15.01M12.13M14.21M57.13M14.29M19.59M14.07M13.39M88K1.9M22.84M11.31M4.33M3.11M35.95M29.44M25M8.06M11.2M0011.08M9.4M0000
Current Ratio2.92x3.57x4.20x3.20x2.44x2.04x2.21x2.44x2.37x2.46x2.06x2.33x2.04x2.10x1.70x2.30x1.98x2.02x3.03x2.25x2.05x2.41x2.05x2.11x---
Quick Ratio1.86x2.25x2.82x2.02x1.43x1.21x1.27x1.67x1.43x1.50x1.35x1.48x1.29x1.32x1.08x1.50x1.25x1.49x2.24x1.47x1.31x1.46x1.49x1.44x---
Cash Conversion Cycle152.51161.15155.73130.01126.2597.36107.97104.72110.6694.2899.98100.1477.8863.5754.4191.4988.1278.3863.8570.5666.1990.5642.9110.26---
Total Non-Current Liabilities2.61B1.54B1.46B1.55B1.75B1.95B1.95B2.19B2.22B2.46B2.93B2.1B1.94B1.15B1.17B1.29B640.88M406.7M472.77M532.19M577.17M593.5M576.38M185.57M000
Long-Term Debt2.08B993.95M992.36M1.13B1.35B1.48B1.48B1.73B1.8B1.99B2.19B1.63B1.59B934.41M970.9M1.12B486.94M294.56M374.79M407.68M459.8M494.9M491.63M146.69M000
Capital Lease Obligations146.52M38.92M43.36M7.7M11.54M20.59M26.52M29.5M0000000000000000000
Deferred Tax Liabilities1.89B500.67M419.59M403.6M380.43M444.92M434.05M407.81M399.57M442.52M715.09M469.62M351.57M213.2M194.29M167.72M153.93M112.14M97.98M122.14M114.57M98.6M84.75M38.87M000
Other Non-Current Liabilities5.55M5.58M5.39M9.19M8.16M7.48M8.61M25.44M20.05M23.33M17.97M2.84M2.46M327K000002.38M2.8M000000
Total Liabilities2.78B1.66B1.57B1.66B1.91B2.09B2.07B2.34B2.35B2.58B3.09B2.2B2.04B1.23B1.26B1.36B695.09M462.35M507M570.08M618.08M629.24M615.29M200.11M98.2M115.3M105.26M
Total Debt2.12B1.05B1.04B1.14B1.37B1.51B1.51B1.77B1.8B1.99B2.19B1.63B1.59B934.41M970.9M1.12B486.94M324.14M378.34M411.23M463.35M498.63M495.36M148.69M000
Net Debt2.08B981.56M946.37M1.09B1.31B1.48B1.48B1.67B1.77B1.96B2.15B1.6B1.57B906.08M955.23M1.1B473.61M283.05M343.16M405.15M449.59M490.43M490.03M145.3M-3.53M-7.88M0
Debt / Equity1.09x0.55x0.57x0.69x0.94x0.95x1.12x1.51x1.64x1.69x2.67x2.18x2.53x1.66x2.03x2.79x1.35x0.99x1.29x0.86x1.04x1.22x1.28x1.18x---
Debt / EBITDA6.48x3.07x2.85x3.05x133.90x4.16x4.62x5.52x18.12x7.99x9.48x5.72x7.05x4.62x4.73x9.90x5.65x3.52x-3.90x4.28x5.12x4.66x6.69x---
Net Debt / EBITDA6.33x2.88x2.58x2.93x128.17x4.09x4.53x5.22x17.84x7.86x9.30x5.63x6.96x4.48x4.66x9.73x5.49x3.07x-3.84x4.15x5.04x4.61x6.54x-0.11x-0.42x-
Interest Coverage4.22x7.08x6.97x5.11x-0.36x5.08x3.48x2.98x0.64x3.03x2.18x2.84x2.57x2.48x2.26x2.48x2.78x3.30x-5.92x--------
Total Equity1.94B1.89B1.83B1.66B1.45B1.58B1.36B1.17B1.1B1.18B822.55M744.34M627.62M563.36M477.94M402.73M361.83M329.06M294.38M479.07M445.33M409.41M385.85M126.51M43.86M58.74M46.03M
Equity Growth %15.02%2.87%10.86%14.37%-8.27%16.15%16%6.86%-7.02%43.29%10.51%18.6%11.41%17.87%18.68%11.3%9.96%11.78%-38.55%7.58%8.78%6.11%204.99%188.45%-25.33%27.61%-
Book Value per Share40.8638.7436.6432.9829.0131.0326.8422.9021.0522.0215.4114.0111.9210.769.297.947.196.575.909.578.908.1914.014.760.882.131.73
Total Shareholders' Equity1.94B1.89B1.83B1.66B1.45B1.58B1.36B1.17B1.1B1.18B822.55M744.34M627.62M563.36M477.94M402.73M361.83M329.06M294.38M479.07M445.33M409.41M385.85M126.51M43.86M58.74M46.03M
Common Stock563K562K560K555K548K544K540K538K536K534K533K530K525K520K513K505K503K502K501K501K501K501K500K0000
Retained Earnings1.8B1.75B1.56B1.34B1.13B1.21B1.01B844.1M701.82M736.28M396.71M327.31M227.41M149.15M76.25M10.74M-26.19M-55.41M-87.52M99.25M65.33M29.26M6.78M1.79M000
Treasury Stock-441.99M-439.3M-277.21M-219.62M-189.11M-133.65M-130.73M-117.62M-59.93M-7.67M-6.59M-5.16M-3.48M-1.43M-687K-687K-416K-63K-63K-47K-40K-30K-4K0000
Accumulated OCI-28.33M-28.37M-37.66M-34.49M-31.56M-19.03M-19.8M-44.16M-25.75M-19.32M-26.35M-23.52M-23.41M739K-104K-13K-2.77M-2.45M-1.33M-999K313K1.11M320K0000
Minority Interest000000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Acquisition-driven leverage spike

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Balance Sheet Expansion via Acquisition

Total assets jumped from $3.5B to $4.6B in 2027Q1, driven by a $1.0B acquisition, while debt more than doubled to $2.1B, per reported figures.

The sequential increase in total assets and debt in 2027Q1 indicates a strategic pivot toward M&A, consistent with the cash flow statement's $1.0B acquisition outlay. This expansion appears to be debt-funded, as equity remained flat at $1.9B, suggesting the company is leveraging its balance sheet to pursue growth. Investors should monitor whether this acquisition generates sufficient returns to justify the increased leverage, especially given the prior top-line contraction.

Leverage Doubles on Acquisition

Debt-to-equity surged from 0.55 in 2026Q4 to 1.08 in 2027Q1, with total debt rising to $2.1B, according to the latest balance sheet data.

The doubling of leverage in a single quarter reflects a deliberate use of debt to finance the acquisition, moving PBH from a conservative to a moderately leveraged position. While the absolute D/E of 1.08 is not extreme, the rapid increase warrants attention, especially if the acquired assets fail to generate expected cash flows. The company's historical ability to generate strong operating cash flow may support debt service, but the sustainability of this leverage depends on the integration success and revenue recovery.

Goodwill and PPE Signal Asset-Light Shift

Goodwill rose to $650.8M in 2027Q1 from $581.1M in 2026Q4, while net PPE increased to $164.2M, reflecting acquisition-related intangibles and minimal fixed assets.

The increase in goodwill and intangibles from the acquisition underscores PBH's brand-centric, asset-light model, where value lies in consumer franchises rather than physical assets. Net PPE remains modest at 3.6% of total assets, confirming reliance on contract manufacturers. The growing goodwill balance raises impairment risk if acquired brands underperform, but the company's history of successful brand integration suggests a lower probability of write-downs.

Retained Earnings Steady, Equity Flat

Retained earnings grew to $1.8B in 2027Q1 from $1.7B in 2026Q4, while total equity remained at $1.9B, as per the balance sheet data.

The modest increase in retained earnings reflects continued profitability, but total equity did not grow, indicating that the acquisition was financed entirely with debt rather than equity issuance. This suggests management is confident in the deal's cash-generating potential, but it also means shareholders bear the risk of higher leverage. The lack of dilution is positive, yet the flat equity base implies that future growth will rely on debt capacity or retained earnings.

Liquidity Remains Strong Despite Cash Dip

Current ratio improved to 3.23 in 2027Q1 from 3.57 in 2026Q4, while cash dropped to $89.1M from $63.9M, based on reported quarterly figures.

Despite the cash outflow for the acquisition, the current ratio remains above 3.0, indicating ample short-term liquidity to cover obligations. The slight decline in the current ratio from 3.57 to 3.23 is not concerning, as it still provides a substantial buffer. However, the cash balance of $89.1M is relatively low compared to the $2.1B debt, suggesting that PBH may rely on operating cash flow to service debt rather than cash reserves.

Acquisition Debt Masks Underlying Stability

The 2027Q1 debt surge to $2.1B, with D/E at 1.08, may distort the balance sheet's otherwise healthy profile, as per the latest data.

The headline leverage metrics are heavily influenced by the recent acquisition, which may not be indicative of PBH's ongoing capital structure. Excluding the acquisition, the company had maintained a conservative D/E around 0.55-0.69 over the prior nine quarters. Investors should assess the acquisition's contribution to cash flows and whether the increased debt is a temporary spike or a new normal. The risk is that if the acquisition fails to deliver expected synergies, the higher leverage could strain future financial flexibility.

PBH — Frequently Asked Questions

Quick answers to the most common questions about buying PBH stock.

What are the total assets of Prestige Consumer Healthcare Inc. (PBH)?

As of 2026, Prestige Consumer Healthcare Inc. (PBH) had total assets of $3.55B including $431.5M in current assets.

How much debt does Prestige Consumer Healthcare Inc. (PBH) have?

Prestige Consumer Healthcare Inc. (PBH) carries total debt of $1.05B, offset by $63.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Prestige Consumer Healthcare Inc.?

Prestige Consumer Healthcare Inc. (PBH) has total shareholders' equity (book value) of $1.89B ($38.74 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Prestige Consumer Healthcare Inc.'s current ratio and liquidity?

Prestige Consumer Healthcare Inc. (PBH) reported a current ratio of 3.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.